Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
MGNX vs. ETF Alternatives
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.
Other News & PR